Deep Intelligence Across Industries

Company Headquarters: Abano Terme, Veneto, Italy Founded: 1946 Workforce: 1001-5000 Company Working: Fidia Farmaceutici s.p.a. manufactures, markets, develops, and sells medical devices, medical products, and dietary supplements based on hyaluronic acid and its derivatives. The company has its distribution networks in the EMEA, Asia, and the US. It sells its products in more than 70 countries and has three international subsidiaries. Its products have been marketed for over 70 years and have prominent brand recognition. It provides products and services to private laboratories, clinics, physicians’ offices, and hospitals and critical care centers, through direct sales and a wide network of distributors across the world.

Company Headquarters: Pennsylvania, Pennsylvania, US Founded: 2013 Workforce: 320+ Company Working: Spark Therapeutics, Inc. is a research-based company which is involved in development and marketing of products related to the gene therapy. The company focuses on developing effective treatments for disorders such as inherited retinal diseases (IRDs), neurodegenerative diseases, lysosomal storage disorders, blindness, hemophilia, and other genetic diseases. Their products are unique and used for the treatment of rare disorders. Moreover, the company is developing innovative products with the help of research and development department, its preclinical trials are focused on developing treatment for inherited retinal diseases. Spark Therapeutics, Inc. has state-of-the-art cGMP manufacturing facility which is approved by Food and Drug Administration (FDA).

Company Headquarters: Amsterdam, Netherlands Founded: 1998 Workforce: 200+ Company Working: uniQure N.V. is engaged in development, manufacturing, and marketing of gene therapy products in the Europe and Americas. The company offers innovative technology, manufacturing platforms, and finished products for the treatment of rare disorders such as hemophilia B, Huntington’s disease, hemophilia A, Fabry disease, and central nervous system disorders. The company offers preclinical services, provide support to the development of drugs, manufacturing and marketing of gene therapy products related to the liver/metabolic, central nervous system and other chronic disorders.

Company Headquarters: Cambridge, Massachusetts, US Founded: 2013 Workforce: 500+ Company Working: Brammer Bio is formed by the merger of Florida Biologix and Brammer Biopharmaceuticals.it is a prominent player in the global viral vector manufacturing market. The company is an experienced player in the contract development and manufacturing segment. The company has delivered more than 100 projects in the last 5 years and established collaboration with major clients to strengthen its position in the market. Brammer Bio offers end to solution to the biotechnology and pharmaceutical companies and has strong presence in the US. The company provides pre-clinical process and analytical development, process scale-up, process optimization, clinical and commercial supply of drug substances, process & analytical qualification, and formulated drug products.

Company Headquarters: North Carolina, US Founded: 2011 Workforce: 501-1000 Company Working: FUJIFILM Diosynth Biotechnologies U.S.A., Inc. is a leading contract development and manufacturing organization focused on manufacturing and marketing of products related to the cell culture, microbial fermentation, and viral vectors. The company mainly focuses on manufacturing of recombinant proteins, viral vaccines and gene therapies for the treatment of rare disorders. The company has three manufacturing facilities which are compatible with cGMP standards. The company has product approval and manufacturing license for 8 products, and it has produced over 3,500 cGMP batches.

Company Headquarters: Lyon, France Founded: 1995 Workforce: 1400+ Company Working: Novasep is a big name in molecule production and purification business and provides products and services to the life sciences and chemical companies. The company operates in business segments namely, pharmaceuticals, biopharmaceuticals, fine chemicals, agrochemicals, food ingredients, functional ingredients, and fermentation and chemical commodities. Moreover, the company offers contract development and manufacturing services to the other industry players. The company operates through its 11 manufacturing sites which are approved by Food and Drug Administration(US) and cGMP certification.

Company Headquarters: Kuopio, Finland Founded: 1997 Workforce: 100+ Company Working: FinVector Vision Therapies was previously known as Ark Therapeutics Limited and it is a major player in the market which is involved in research and development of viral-based gene therapy products. The company develops and manufactures products used for gene therapy through its manufacturing facility which is approved by European Medicines Agency(EMA). It offers services and viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. The company operates in business segments namely, cell banking and viral seed stocks, R&D cell/gene therapy unit, platform process development / scale up, assay development and analytical testing, cGMP Manufacturing capabilities, FinVector aseptic filling capability, stability studies, Viral Vectors (including Adeno, AAV, Lenti), and Others.

Company Headquarters: Oxford, Oxfordshire, UK Founded: 1995 Workforce: 330+ Company Working: Oxford BioMedica is the first company to treat humans with the help of lentivirus and it is a leading player in the global cell and gene therapy market. The company develops and markets LentiVector technology which is widely used by physicians as a part of cell and gene therapy. The company operates in major markets in developed countries such as Americas and Europe. It has 20+ years’ experience in gene therapy segment and the company has conducted trials in more than 140 countries. The company has long term product related partnerships with major pharmaceutical players such as Novartis, orchard therapeutics, Sanofi, GlaxoSmithKline and has research and devleopmnet collaboration with Green Cross Labcell.

Company Headquarters: Keele, Northern Staffordshire, England Founded: 1992 Workforce: 201-500+ Company Working: Cobra Biologics was formerly known as RecipharmCobra Biologics Limited and operates as a subsidiary of Recip AB. it is a major player in the contract development and manufacturing (CDMO) segment which provides services such as pre-clinical, clinical, and commercial supply. The company operates in more than 18 counties and has manufacturing unit in Södertälje, Sweden. The company offers API services in pre-filled syringes, freeze drying/lyophilization, and injectable vial fill finish. It operates through DNA, viral vectors, technical proteins, microbiota, fill finish and other segments. The company has a strong research and development with more than 320 products in pipeline.